Eds & Meds NYC 2020
Pilot Health Tech NYC is an initiative launched in 2013 by the City of New York and the New York City Economic Development Corporation (NYCEDC). In a strategic review of the life sciences and healthcare sectors in New York City called Eds & Meds NYC 2020, the NYCEDC identified a portfolio of initiatives to support companies and entrepreneurs across the value chain, addressing unmet needs identified by senior stakeholders in both the healthcare and life sciences communities, including opportunities for collaboration, funding, and human capital development.
NYCEDC conducted extensive conversations with healthcare providers, senior academic stakeholders, investors and entrepreneurs in NYC and beyond. According to stakeholders, there was consensus that the City can play a more active role in championing an entrepreneurial culture among NYC's health tech communities and encouraging healthcare technologies to leverage NYC's strong clinical care, payor, and technology community.
This study led to the creation of a portfolio of initiatives aimed at addressing key needs in the healthcare technology and life sciences sector, including Pilot Health Tech NYC. Other initiatives include:
- Entrepreneurship Lab for Bio & Health Tech, a mini-MBA and mentorship for aspiring entrepreneurs;
- SBIR IMPACT NYC, which provides workshops and one-on-one assistance to help companies apply for federal funding;
- Harlem Biospace, which provides affordable wet-lab and office space for early-stage companies;
- Life Sciences Funding Initiative, which will provide $100 million in early-stage support for life science and digital health companies in partnership with Celgene, Eli Lilly & Company and GE Ventures.
The New York City Economic Development Corporation (NYCEDC) is the City's primary vehicle for promoting economic growth in each of the five boroughs. NYCEDC's mission is to stimulate growth through expansion and redevelopment programs that encourage investment, generate prosperity and strengthen the City's competitive position. NYCEDC serves as an advocate to the business community by building relationships with companies that allow them to take advantage of New York City's many opportunities. Find us on Facebook or follow us on Twitter, or visit our blog to learn more about NYCEDC projects and initiatives.
Health 2.0 is a healthcare technology conference, media and innovation consulting company, which manages one of the broadest and most diverse health care innovation networks in the U.S. today. Health 2.0's Developer Challenge is a platform supporting a series of innovation competitions in which developers, designers, and entrepreneurs can work together with sponsoring organizations to tackle important health system problems. Health 2.0 is working with NYCEDC to overall manage the Pilot Health Tech NYC program to support healthcare innovation in New York City.
AdhereTech has created wireless smart pill bottles that improve medication adherence. Dr. Roy Gulick is a Professor of Medicine at Weill Cornell and the Principal Investigator of the Cornell HIV Clinical Trials Unit. AdhereTech will be working with Dr. Gulick and his team to assess patient adherence to an HIV drug regimen (tenofovir-based) over 12 weeks using AdhereTech bottles with reminders and feedback, compared to the usual standard of care.
BioDigital and Memorial Sloan-Kettering are addressing deficiencies in patient-doctor communication through the use of new visualization technology. BioDigital's Human Platform, an interactive 3D virtual body that is already widely used in academia, will be introduced into the Memorial Sloan-Kettering clinical workflow as a tool to more effectively communicate complex health topics. The expected results include increased patient engagement, understanding and satisfaction - all while saving doctors time.
Each year, in the USA alone, over 12M patients present to emergency departments in an altered mental state, in need of an electroencephalogram, but cannot get one. microEEG is an FDA approved, miniature, wireless system that utilizes a rapid-to-apply disposable electrodes and a network of teleneurologists to provide a remote, rapid interpretation to an ED physician. Utilizing microEEG in the ED can influence patient management and thus alter economic outcomes.
This pilot will test the outcomes of the eCaring web-based care management & monitoring system with a high need population of chronically ill, multicultural older adults in Henry Street Settlement’s Vladeck Cares Naturally Occurring Retirement Community (NORC). Patients & their caregivers will be randomly selected to receive eCaring for 6 months. Pace RN’s will track data & assess the effect on use of healthcare resources, disease management, preventable events, & costs.
Flatiron Health is building a “big data” software platform that aggregates, cleans and structures clinical oncology data in order to provide applications to care providers. This pilot will enable Continuum Health Partners to measure and improve a wide range of metrics relating to cancer care at their centers. These include comprehensive quality, operational, clinical, and financial performance data.
Diabetics must measure their blood glucose despite being painful and inconvenient. We have developed a better way to measure blood glucose in the 17 million Type II diabetics: through ocular tears. Our technology consists of a pen shaped device with glucose sensing chemistry at the tip that gently touches the tears just above the lower eyelid. Our pilot will measure the correlation between tear and blood glucose in diabetic patients.
SelectHealth and Rip Road are partnering to develop a new member engagement model for Medicaid members. Rip Road's text messaging engagement platform will be used for member communications and patient data analysis. We will focus on member adherence to appointments and medication refills. By providing this new engagement channel, we seek to improve health outcomes, increase member retention and satisfaction with SelectHealth, and reduce hospitalizations and long-term care costs.
Sense Health is working with University Behavioral Associates (affiliated with Montefiore) to pilot their mobile patient support technology with case managers and patients in the Managed Addiction Treatment Services Program. If successful, this pilot will validate a technology that efficiently helps case managers deliver high intensity support to growing patient case loads.
StarlingHealth and VillageCare are partnering to pilot the use of a nurse call and bedside communication system to improve patient care and satisfaction while reducing cost of care delivery at VillageCare Center for Rehabilitation and Nursing, a 105-bed sub-acute facility. Residents will use multi-lingual touchscreen tablets to make specific requests. Automatic request delegation, routing and escalation will help staff resolve needs, and management will have real-time visibility into all activities.
Vital Care Services and Pace University will pilot the effectiveness of TeleHealth solutions to meet current and projected needs of diverse socio-economic communities in New York City. Pace student technicians will assist patients in taking their vitals, which are monitored remotely by a Pace RN. Key objectives of the pilot are to reduce healthcare cost, increase access and quality of care, and train future working professionals at the University level.